---
figid: PMC11504336__antioxidants-13-01210-g003
figtitle: Role and mechanism of Grx1 and Grx2 in protection against PCO formation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11504336
filename: antioxidants-13-01210-g003.jpg
figlink: /pmc/articles/PMC11504336/figure/F3/
number: F3
caption: Role and mechanism of Grx1 and Grx2 in protection against PCO formation.
  Reduced Grx1, present in PCO formation and LECs under oxidative stress, promotes
  EMT of LECs and aggravates PCO by upregulating glutathionylation at cysteine 249
  of CK1α. This upregulation blocks degradation of β-catenin, enhances the nuclear
  translocation of β-catenin, and activates the Wnt/β-catenin signalling pathway.
  Additionally, increased ILK, induced by Grx2 deficiency, phosphorylates AKT and
  GSK-3β, thereby further blocking degradation of β-catenin, enhancing the nuclear
  translocation of β-catenin, and activating the Wnt/β-catenin signalling pathway,
  which promotes PCO formation and EMT in LECs
papertitle: Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior
  Capsular Opacification
reftext: Chenshuang Li, et al. Antioxidants (Basel). 2024 Oct;13(10).
year: '2024'
doi: 10.3390/antiox13101210
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: posterior capsular opacification | epidemiology | pathogenesis | oxidative
  stress | glutaredoxins | advanced antioxidative pharmacological agent
automl_pathway: 0.9519316
figid_alias: PMC11504336__F3
figtype: Figure
redirect_from: /figures/PMC11504336__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11504336__antioxidants-13-01210-g003.html
  '@type': Dataset
  description: Role and mechanism of Grx1 and Grx2 in protection against PCO formation.
    Reduced Grx1, present in PCO formation and LECs under oxidative stress, promotes
    EMT of LECs and aggravates PCO by upregulating glutathionylation at cysteine 249
    of CK1α. This upregulation blocks degradation of β-catenin, enhances the nuclear
    translocation of β-catenin, and activates the Wnt/β-catenin signalling pathway.
    Additionally, increased ILK, induced by Grx2 deficiency, phosphorylates AKT and
    GSK-3β, thereby further blocking degradation of β-catenin, enhancing the nuclear
    translocation of β-catenin, and activating the Wnt/β-catenin signalling pathway,
    which promotes PCO formation and EMT in LECs
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MROS
  - GLRX2
  - LRP5
  - LRP6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ILK
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - CSNK1A1
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CTNNB1
  - GLRX
  - HNF4A
  - CDH1
  - FZR1
  - CDH2
  - TWIST1
  - ACTA1
  - SNAI1
  - ITK
  - SLC22A3
  - ZEB1
  - ROS
  - nucleus
---
